Search Tag: Joseph Damasio
2022 08 Aug
Biostage, Inc. , a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer (conducted at the Mayo Clinic and published last August) and FDA approval to commence a clinical trial of the Biostage Esophageal Implant for severe esophageal disease including cancer announced the appointment of Joseph Damasio...Read more